Home › Funds › Affinity Asset Advisors, LLC › SGMT

Affinity Asset Advisors, LLC position in SGMT

SAGIMET BIOSCIENCES INC · Health Care

Affinity Asset Advisors, LLC reported holding 2,527,384 shares of SGMT (SAGIMET BIOSCIENCES INC) in its Q3 2026 13F filing — a position valued at US$25.0M, representing 1.16% of its reported portfolio and ranking #24 among its reported holdings. Affinity Asset Advisors, LLC has disclosed SGMT holdings in 5 of the last 5 reported quarters, going back to Q3 2025.

Latest position (Q3 2026)2.53M sh
Reported value held$24.97M
Portfolio Weight1.16%
First reportedQ3 2025
Last changeAdd
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How Affinity Asset Advisors, LLC's SGMT position evolved

Affinity Asset Advisors, LLC first disclosed a stake in SGMT in Q3 2025 at 350,000 shares (US$2.4M). The position peaked in Q3 2026 at 2,527,384 shares, worth US$25.0M. Across 5 filings, Affinity Asset Advisors, LLC increased the stake 3 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 2,527,384 shares valued at US$25.0M — an increase of 29,520 shares quarter over quarter.. Notable position changes include a 228% increase in Q4 2025 (shares fell 12% over the following quarter), a 188% increase in Q2 2026 (shares rose 28% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2025 350.00K $2.40M New
Q4 2025 1.15M $6.80M Add
Q1 2026 868.02K $4.54M Reduce
Q2 2026 2.50M $19.31M Add
Q3 2026 2.53M $24.97M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About SGMT and 13F data

SGMT (SAGIMET BIOSCIENCES INC) is a Health Care company. 59 other funds we track also report a position in SGMT — the largest reported positions include SILVERARC CAPITAL MANAGEMENT, LLC (US$37.0M), BVF INC/IL (US$19.3M), Caligan Partners LP (US$19.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding SGMT

All SGMT fund holders →

FAQ

How long has Affinity Asset Advisors, LLC held SGMT?

Affinity Asset Advisors, LLC has disclosed SGMT holdings in 5 of the last 5 reported quarters, going back to Q3 2025.

What is Affinity Asset Advisors, LLC's current position in SGMT?

As of Q3 2026, Affinity Asset Advisors, LLC holds 2.53M shares of SGMT (SAGIMET BIOSCIENCES INC), valued at $24.97M, representing 1.16% of its reported portfolio and ranking #24.

Has Affinity Asset Advisors, LLC been buying or selling SGMT?

In the latest 13F filing (Q3 2026), Affinity Asset Advisors, LLC increased its position in SGMT. The position peaked in Q3 2026 at 2.53M shares.

Which other funds hold SGMT?

Other major institutional holders of SGMT include SILVERARC CAPITAL MANAGEMENT, LLC, BVF INC/IL, Caligan Partners LP, among 59 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.